Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Abstract

UNLABELLED TNFs are major mediators of inflammation and inflammation-related diseases, hence, the United States Food and Drug Administration (FDA) has approved the use of blockers of the cytokine, TNF-α, for the treatment of osteoarthritis, inflammatory bowel disease, psoriasis and ankylosis. These drugs include the chimeric TNF antibody (infliximab… (More)
DOI: 10.1111/bph.12131

Topics

Cite this paper

@article{Aggarwal2013CurcuminAO, title={Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.}, author={Bharat Bhushan Aggarwal and Subash Chandra Gupta and Bokyung Sung}, journal={British journal of pharmacology}, year={2013}, volume={169 8}, pages={1672-92} }